Ferric Maltol Suggested as Promising New Therapy for Iron Deficiency Anemia in ‪#IBD‬ Patients

Ferric Maltol Suggested as Promising New Therapy for Iron Deficiency Anemia in ‪#IBD‬ Patients
A multicenter phase-3 clinical trial study published in the journal Inflammatory Bowel Diseases, revealed that ferric maltol, a ferric iron compound, has the potential to be used as a new oral treatment for iron deficiency anemia in patients with inflammatory bowel disease (IBD). The study is entitled “Ferric Maltol Is Effective in Correcting Iron Deficiency

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *